Skip to content
A

Ayşe Özdemir

Publications (3)

A Simple LC-MS/MS Method for Determination of Vemurafenib in Rat Plasma Fed with High Fat Diet

Ayşe Özdemir, Senem Şanli & Erten Akbel · Journal of Pharmaceutical Research International · 2021

In this study, high fat diet was fed to rats and the amount of vemurafenib in rat plasma was determined by the developed liquid chromatography with tandem mass spectrometry. The calibration curve was linear between 0.01 and 0.8 µg mL−1 vemurafenib with 0.999 regression coefficien...

Open access Research Article 10.9734/jpri/2021/v33i40B32285

Determination of pKa and Degradation Products of the Mutated BRAF Inhibitor Vemurafenib and UPLC Assay in Human Urine

Senem Şanli, Ayşe Özdemir, Gülşen Güven & Süleyman Gökçe · Journal of Pharmaceutical Research International · 2020

In this study, the pKa value of vemurafenib was determined by the dependence of the retention factor on the pH of the mobile phase. The change of pKa in the different acetonitrile fraction ranging between 57.5 and 62.5% (v/v) was studied by using an LC-UV method. Additionally, a...

Open access Research Article 10.9734/jpri/2020/v32i3630986

Prevalence of Vitamin D Deficiency among University Students in Uşak, Turkey

Saygın Kamacı, Senem Şanlı, Ayşe Özdemir, Seyfi Sardoğan, Sanem Erdoğan & Nurullah Şanlı · Journal of Pharmaceutical Research International · 2020

Vitamin D deficiency is now recognized as a pandemic with implications for multi-organ systems including bone health and immunological processes. Low levels have been associated with several chronic and infectious diseases. The aim of the study was to evaluate the prevalence of v...

Open access Research Article 10.9734/jpri/2020/v32i2230781